Protagenic Therapeutics Valuation
| PTIX Stock | USD 0.40 0.09 18.37% |
Protagenic Therapeutics is undervalued. Protagenic Therapeutics holds a recent Real Value of $1.3 per share. The prevailing price of the company is $0.4. Our model determines the value of Protagenic Therapeutics from analyzing the company fundamentals such as Shares Outstanding of 1.93 M, return on equity of -5.13, and Shares Owned By Institutions of 6.46 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Protagenic Therapeutics' valuation include:
Undervalued
Today
Please note that Protagenic Therapeutics' price fluctuation is abnormally volatile at this time. Calculation of the real value of Protagenic Therapeutics is based on 3 months time horizon. Increasing Protagenic Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Protagenic Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Protagenic Stock. However, Protagenic Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.4 | Real 1.3 | Target 4.0 | Hype 0.33 |
The intrinsic value of Protagenic Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Protagenic Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Protagenic Therapeutics helps investors to forecast how Protagenic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Protagenic Therapeutics more accurately as focusing exclusively on Protagenic Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Protagenic Therapeutics' intrinsic value based on its ongoing forecasts of Protagenic Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Protagenic Therapeutics' closest peers.
Protagenic Therapeutics Cash |
|
About Protagenic Therapeutics Valuation
Our relative valuation model uses a comparative analysis of Protagenic Therapeutics. We calculate exposure to Protagenic Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Protagenic Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -45.3 K | -43 K | |
| Pretax Profit Margin | (0.59) | (0.62) | |
| Operating Profit Margin | (0.64) | (0.67) | |
| Net Loss | (0.57) | (0.60) | |
| Gross Profit Margin | (0.08) | (0.07) |
Protagenic Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Protagenic Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Protagenic we look at many different elements of the entity such as Protagenic's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Protagenic Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Protagenic Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Protagenic Therapeutics' worth.Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.